US Patent Issued to TONRON INTERNATIONAL on July 7 for "Mycobacterium for use in cancer therapy" (Dutch, British Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,074, issued on July 7, was assigned to TONRON INTERNATIONAL Ltd. (Airdrie, Great Britain).

"Mycobacterium for use in cancer therapy" was invented by Jakob Kampinga (Groningen, Netherlands) and Thomas Kleen (Uxbridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides an immunomodulator for use in the treatment, reduction, inhibition or control of cancer subject, wherein the subject is clinically classified as having a performance status of 1-, 2, 3 or 4 according to the ECOG Scale, or classified as not being of an age and/or not being sufficiently fit to tolerate two or more chemotherapy regimens. The invention also ...